Antinuclear antibodies are extremely sensitive for systemic lupus erythematosus; most patients with SLE have ANA detectable, which is why it’s used as a first screening test when lupus is suspected. A positive ANA strongly supports the possibility of SLE, although it’s not specific—many other autoimmune diseases and even some healthy people can have a positive result. Because of that, a positive ANA prompts follow-up testing with more disease-specific antibodies (like anti-dsDNA or anti-Smith) to confirm and refine the diagnosis. In the other conditions listed, ANA can be present but not as consistently or characteristically as in SLE, making systemic lupus erythematosus the disease for which ANA testing is most sensitive.

BUN rises when the kidneys aren’t clearing urea effectively or when more urea is produced from protein breakdown. Sepsis fits this by commonly causing acute kidney injury from reduced blood flow and inflammatory damage, along with a hypercatabolic state that increases protein breakdown and urea production. This combination pushes BUN higher. While other conditions can influence BUN, sepsis is the scenario here that most consistently leads to an elevated BUN due to both impaired clearance and increased production.

Ketones are produced when fatty acids are broken down for energy, especially during fasting or low carbohydrate intake. In the liver, fatty acids undergo beta-oxidation to yield acetyl-CoA. If carbohydrate supply is limited, oxaloacetate is diverted to gluconeogenesis, restricting the entry of acetyl-CoA into the citric acid cycle. The excess acetyl-CoA is then used to form ketone bodies—acetoacetate, beta-hydroxybutyrate, and acetone—which are released into the bloodstream and used by tissues (like the brain and muscle) as an alternative energy source during prolonged fasting. Thus, the end products of fatty acid breakdown in this context are ketone bodies.

Elevated thyroid-stimulating immunoglobulins (TSI) are autoantibodies that bind to and activate the TSH receptor on thyroid cells, mimicking TSH and driving increased production of thyroid hormones. This antibody pattern is most characteristic of Graves disease, where TSI cause diffuse, hyperfunctioning thyroid activity and are often linked with other Graves features like eye signs. In Hashimoto's thyroiditis, the immune system mainly produces anti-thyroid peroxidase and anti-thyroglobulin antibodies, leading to hypothyroidism rather than TSI-mediated hyperthyroidism. Subacute thyroiditis involves inflammatory destruction of the thyroid with release of preformed hormones, not stimulation via TSH receptors, so TSI are not elevated. Goiter simply denotes thyroid enlargement from various causes and does not specifically indicate elevated TSI.